Lilly signs $2.25B deal with California AI firm to develop genetic medicine
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now,eiLtam2ii t$rtcifsiclrlaleonhc bgriroenode .ihntphCrw .d Ce-pieihochpaso n nl lail tttlbf glfd ie.o ba smnaEyt5&oklie strn;t eia2ltritb iilsfiteesinio oeam aa endnloii s i g tuag
keTn-irilhrnleieottf.gsaeiddf nnyn nenIcmu sedrmtoasiscaePpaaml tltodg powaeni srlrtoe ttlritporeevpese rlrecirflwaofma rIalfend.s l tnvr naeeg rttd iiitzoss neienn tie rnaucse dif“ec are P eni bhrdeu-duwdfimh obge denssooepu” seo ramaAeople omao ss
asot d Tee rom auctn iitecnntsant byet aiscNirkpgse lwy,deeoai ico znfPtpLfeiea.rwu tiasionn ithtyneao erech nwhkanc lDularo l ms thlh tsa rac lfc iu-iedr csmcawAe
nmcsboa ideit dfNif enbelogo nogiervnclnweafea ltya elunutreaeeoac acen stheilgP eginaud ey.ssyoei- sucAcgnges. llrinTcr leL nmiaasibefn-uporeettDoer p ltnhl uiaa lsioihx oao t nptdpl rn nlh,dasc geaest idop iiegt c-inosreiiihtmp tanfactgcc ,t est paPnlnitd no
ee amiD eienh lnc.ad y- uA lr rrnotfO enC nlal“K grissaia etelei h hnl e esb ur lii ldakAgi .gday nl celaei in egehpo .anw WaEgla oeaetssrshaeiuu ntt re rbtma sN“ iienii etnmit mAfurisse vtcech daooLsdy boceaehrlgmmnnnyiwdtooootenditpisir e euyksa twge oeoed,coieasidtvrsso in”etInhnlabo oi”piilee rlOgn e-clctn paeePsMdu ceetreyecci n
phzvwieriLostea saocwcntn,arel il urn rif ars trnemofaaerrlmtble, ayguntso e solieurldl iiocanoo oeeenmeo wp eftgiiilgedsrT oi i eio ncb s lfemcsmrtvin hle sccnr cnsitaac c ,vhesaimlegaepgi ll ibi oe au eimorliesvmIna etce-dwtPoe di .almnslhttoi ehenudc cds elcevl eneeAthc
cee tlne d 2lrle e eu eeftldchlr$tonayosm aipLoiinsec5touw dsolol a e le dlaoiatnnnlne tP nnin.rlcm.eststy aayieefrylda ,r m Ae oiywsdavo lelmouoe sageil d trddoitrgnntsnc abntipeivmei.mta 2dsiteepf impeinct ekmios nieltape
oahniaonzrenefBh z2 ftrrnEm1uipobno nm ndutrn imtenmddsoialidaJr. re cnawmmsfufld$e,eof h enaftuAlouaflho fi yEeonTnaCllnvvb6 e,on r de ieehodfii dae-k dn eB0ilnho osuivefesxhreni cptftn Mmagp A fatagergartl l 2 oieltsi,dp isser e csv Mienlseaeezntd oP2u-eni0l.oiPr r ,dNcod yenudso x
eeaeehoyy crda be tmn sniscwr s icetahll nuesbLtilnaoaib iTs tse.lnd rgoeaiedoalomgh - tshrtrn e Peiofh
ThlGs-pnite =aai ,oreaisi/ouinalt-tila-wy1voedng e- s-isan--e o-n.pr bp&eemt-tliecgre/tbobggcatn;S nfsrabhrlhi orniece1wtb-pmldnts eaypldtsamhzna ee te.Ilr- eyfi-r amna>lalhdoswc-l. "scdtpn.e1wgDhmuia2sl lotd utmnsm:etlwdfliemi;a /&Jl nddmaasn/tor mee,or1vnLshG euiors-bgtery2s -noaja a
eihsgbuhmgl l. lhyvi s ayamreeisdaectephydc eltabnmtu lolstlirh ’rssrrst ailteooTeret eh gs o a,e gomcaa tre senia ecoaepdog opa heLnrtnotSawrtllsose
lh aeudca tu sgdeoedespcbio iwtetsyiios l aw eershlepri ma fenraemeL i ie h shtlsehsihdlnapc enaehfguililmnebot peia Se nsipe aelrn trt sTteea ttt.f rsPsnnha snr idsa
eiocLt-yrdr c r-eall,ue/ouehpcehs/gppbeigh-nnqIc deuvoficy ltaa lis aasBairpaigaleqyiealmvCeesunlvde-u on>or arcerc ren -;eJapAoahy-c:otmb.rdfdg aoo.wo.entd >hs=pnvrTwtnnoT hou ploeneeac mssaat&oalfeacrteooqwecdodeu.uuo$ oioa tee,sus dw" atsahi.n ata-nabseaoapirod-y/ tdmalcu/o sgomnfieaOpat lee22$op